Загрузка...
Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
OBJECTIVES: Osteoporosis is a rapidly rising cause of concern for elderly patients. Various classes of drugs are available in the market. Bisphosphonates are considered as a first-line therapy for the prevention and treatment. Denosumab is an antiresorptive agent which is a RANK ligand inhibitor. Th...
Сохранить в:
| Опубликовано в: : | Osteoporos Sarcopenia |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Korean Society of Osteoporosis
2016
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6372735/ https://ncbi.nlm.nih.gov/pubmed/30775470 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2016.03.003 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|